A recent study published in Scientific Reports has indicated that lithium, currently used to treat bipolar disorder and depression, and rapamycin, an anticancer drug, could help to preserve brain function and prevent secondary nerve cell damage in patients with a traumatic brain injury (TBI). The research team from Rutgers University (NJ, USA) investigated the drugs with nerve cells in vitro, finding that cells were successfully protected from glutamate-induced excitotoxicity with both lithium and rapamycin.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.